Thx for caring. She passed last night unfortunately. Multi-organ failure. Her husband is 2 beds down COVID-19 and very ill as well.
Perhaps the TOCI you got for her can go to him.....Marcus Aurelius said:
Thx for caring. She passed last night unfortunately. Multi-organ failure. Her husband is 2 beds down COVID-19 and very ill as well.
very sorry to hear. Prayers being said now.Marcus Aurelius said:
Thx for caring. She passed last night unfortunately. Multi-organ failure. Her husband is 2 beds down COVID-19 and very ill as well.
Rheumatologists: On the COVID-19 Front Line Experience with rheumatic drugs may help in the most severe casesQuote:
The patients enrolled in the trial averaged 56.8 years of age, ranging from 25 to 88, and most were men. Each patient had received a week of standard treatment before receiving tocilizumab. Fever was present in all, dry cough in two-thirds, and fatigue or dyspnea in one-quarter. Twenty patients required oxygen therapy.
All patients had increased levels of C-reactive protein, at a mean of 75 mg/L, and lymphocyte decreases were observed in 85%.
Chest CT scans were abnormal in all patients, typically involving ground-glass opacities and focal consolidation, particularly in the subpleural region.
Within a day of receiving tocilizumab, all patients showed normalization of their temperature. Peripheral oxygen saturation also improved rapidly, and 15 of the patients had a decrease in their requirement for oxygen. Normalization of lymphocyte levels was seen in 10 patients, and C-reactive protein levels also were reduced to normal levels within 5 days. Post-treatment CT scans showed clearance of lesions in 19 patients.
One dose of tocilizumab was given to 18 patients, and an additional dose was given to three patients when fever persisted for 12 hours.
Another report on a 60 yr old male in Wuhan...Marcus Aurelius said:
The authorization to use tocilizumab in our hospital has been given to pulmonary docs like myself. So question to those using it for these patients. Timing? Anyone who requires ICU care? Upon intubation? I don't think it's judicious to use it for all admitted patients.
Quote:
On admission, the patient's arterial oxygen saturation increased to 96% with oxygen supplementation via nasal cannula (3 L/min). Chest CT imaging on hospital day 2 showed bilateral, multiple ground-glass opacities (Figure 1A-C). Considering his sustained chest tightness and shortness of breath, 40 mg of methylprednisolone, administered IV daily, was given on days 2 to 6. The patient then reported that his breathing had improved, but he still felt chest tightness. Chest CT imaging on hospital day 8 showed that the bilateral, multiple ground-glass opacities from the first scan remained (Figure 1D-F), and laboratory investigations revealed a high level of serum IL-6. On hospital day 9 (illness day 24), the patient was given 8 mg/kg tocilizumab, administered IV, 1 time. On hospital day 12, his chest tightness disappeared. After tocilizumab administration, the IL-6 level decreased gradually over the following 10 days (from 121.59 to 20.81 pg/mL), then increased rapidly to the peak (317.38 pg/mL), and then decreased to a low level (117.10 pg/mL) (Figure 2). The transient rebounding of the IL-6 level to the peak does not mean COVID-19 relapse: instead, this might be attributed to the recovery of the normal T cells. On hospital day 19, the patient had a third chest CT scan, which showed that the range of ground-glass opacities had obviously decreased (Figure 1G-I). The patient was declared to be cured and was discharged from the hospital on 13 March 2020. He had no symptoms of MM, and related laboratory findings were all in normal ranges
Quote:
If nothing else this pandemic has again revealed how incredible human ingenuity and willpower really is. Every once in a while we see a global event that tests our limits as a species and we seem to consistently rise to the challenge.